239 related articles for article (PubMed ID: 27751867)
1. PNPLA1 Deficiency in Mice and Humans Leads to a Defect in the Synthesis of Omega-O-Acylceramides.
Grond S; Eichmann TO; Dubrac S; Kolb D; Schmuth M; Fischer J; Crumrine D; Elias PM; Haemmerle G; Zechner R; Lass A; Radner FPW
J Invest Dermatol; 2017 Feb; 137(2):394-402. PubMed ID: 27751867
[TBL] [Abstract][Full Text] [Related]
2. PNPLA1 defects in patients with autosomal recessive congenital ichthyosis and KO mice sustain PNPLA1 irreplaceable function in epidermal omega-O-acylceramide synthesis and skin permeability barrier.
Pichery M; Huchenq A; Sandhoff R; Severino-Freire M; Zaafouri S; Opálka L; Levade T; Soldan V; Bertrand-Michel J; Lhuillier E; Serre G; Maruani A; Mazereeuw-Hautier J; Jonca N
Hum Mol Genet; 2017 May; 26(10):1787-1800. PubMed ID: 28369476
[TBL] [Abstract][Full Text] [Related]
3. PNPLA1 has a crucial role in skin barrier function by directing acylceramide biosynthesis.
Hirabayashi T; Anjo T; Kaneko A; Senoo Y; Shibata A; Takama H; Yokoyama K; Nishito Y; Ono T; Taya C; Muramatsu K; Fukami K; Muñoz-Garcia A; Brash AR; Ikeda K; Arita M; Akiyama M; Murakami M
Nat Commun; 2017 Mar; 8():14609. PubMed ID: 28248300
[TBL] [Abstract][Full Text] [Related]
4. Impaired production of skin barrier lipid acylceramides and abnormal localization of PNPLA1 due to ichthyosis-causing mutations in PNPLA1.
Nohara T; Ohno Y; Kihara A
J Dermatol Sci; 2022 Aug; 107(2):89-94. PubMed ID: 35970721
[TBL] [Abstract][Full Text] [Related]
5. ω-O-Acylceramides but not ω-hydroxy ceramides are required for healthy lamellar phase architecture of skin barrier lipids.
Opálka L; Meyer JM; Ondrejčeková V; Svatošová L; Radner FPW; Vávrová K
J Lipid Res; 2022 Jun; 63(6):100226. PubMed ID: 35568253
[TBL] [Abstract][Full Text] [Related]
6. The role of PNPLA1 in ω-O-acylceramide synthesis and skin barrier function.
Hirabayashi T; Murakami M; Kihara A
Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Jun; 1864(6):869-879. PubMed ID: 30290227
[TBL] [Abstract][Full Text] [Related]
7. [Elucidation of the Synthetic Mechanism of Acylceramide, an Essential Lipid for Skin Barrier Function].
Ohno Y
Yakugaku Zasshi; 2017; 137(10):1201-1208. PubMed ID: 28966260
[TBL] [Abstract][Full Text] [Related]
8. PNPLA1-Mediated Acylceramide Biosynthesis and Autosomal Recessive Congenital Ichthyosis.
Zeng F; Qin W; Huang F; Chang P
Metabolites; 2022 Jul; 12(8):. PubMed ID: 35893253
[TBL] [Abstract][Full Text] [Related]
9. ABHD5 stimulates PNPLA1-mediated ω-
Kien B; Grond S; Haemmerle G; Lass A; Eichmann TO; Radner FPW
J Lipid Res; 2018 Dec; 59(12):2360-2367. PubMed ID: 30361410
[TBL] [Abstract][Full Text] [Related]
10. PNPLA1 is a transacylase essential for the generation of the skin barrier lipid ω-O-acylceramide.
Ohno Y; Kamiyama N; Nakamichi S; Kihara A
Nat Commun; 2017 Mar; 8():14610. PubMed ID: 28248318
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of the ichthyosis pathology of Chanarin-Dorfman syndrome: Stimulation of PNPLA1-catalyzed ω-O-acylceramide production by ABHD5.
Ohno Y; Nara A; Nakamichi S; Kihara A
J Dermatol Sci; 2018 Dec; 92(3):245-253. PubMed ID: 30527376
[TBL] [Abstract][Full Text] [Related]
12. Recombinant PNPLA1 catalyzes the synthesis of acylceramides and acyl acids with selective incorporation of linoleic acid.
Meyer JM; Boeglin WE; Brash AR
J Lipid Res; 2023 Jun; 64(6):100379. PubMed ID: 37087101
[TBL] [Abstract][Full Text] [Related]
13. Corneocyte lipid envelope (CLE), the key structure for skin barrier function and ichthyosis pathogenesis.
Akiyama M
J Dermatol Sci; 2017 Oct; 88(1):3-9. PubMed ID: 28623042
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive stratum corneum ceramide profiling reveals reduced acylceramides in ichthyosis patient with CERS3 mutations.
Yamamoto M; Sassa T; Kyono Y; Uemura H; Kugo M; Hayashi H; Imai Y; Yamanishi K; Kihara A
J Dermatol; 2021 Apr; 48(4):447-456. PubMed ID: 33492757
[TBL] [Abstract][Full Text] [Related]
15. Skin Barrier Development Depends on CGI-58 Protein Expression during Late-Stage Keratinocyte Differentiation.
Grond S; Radner FPW; Eichmann TO; Kolb D; Grabner GF; Wolinski H; Gruber R; Hofer P; Heier C; Schauer S; Rülicke T; Hoefler G; Schmuth M; Elias PM; Lass A; Zechner R; Haemmerle G
J Invest Dermatol; 2017 Feb; 137(2):403-413. PubMed ID: 27725204
[TBL] [Abstract][Full Text] [Related]
16. Severe Skin Permeability Barrier Dysfunction in Knockout Mice Deficient in a Fatty Acid ω-Hydroxylase Crucial to Acylceramide Production.
Miyamoto M; Itoh N; Sawai M; Sassa T; Kihara A
J Invest Dermatol; 2020 Feb; 140(2):319-326.e4. PubMed ID: 31356814
[TBL] [Abstract][Full Text] [Related]
17. Skin permeability barrier formation by the ichthyosis-causative gene
Yamamoto H; Hattori M; Chamulitrat W; Ohno Y; Kihara A
Proc Natl Acad Sci U S A; 2020 Feb; 117(6):2914-2922. PubMed ID: 31974308
[TBL] [Abstract][Full Text] [Related]
18. Impaired Skin Barrier Function Due to Reduced ω-
Nojiri K; Fudetani S; Arai A; Kitamura T; Sassa T; Kihara A
Mol Cell Biol; 2021 Sep; 41(10):e0035221. PubMed ID: 34370553
[TBL] [Abstract][Full Text] [Related]
19. Comparison of skin barrier abnormalities and epidermal ceramide profiles among three ω-O-acylceramide synthesis-deficient mouse strains.
Yamamoto Y; Sassa T; Kihara A
J Dermatol Sci; 2024 Jan; 113(1):10-17. PubMed ID: 38158274
[TBL] [Abstract][Full Text] [Related]
20. Novel Pathogenic Mutation of
Li H; Qian LJ; Xu N; Huang L; Qiao LX
Chin Med Sci J; 2022 Dec; 37(4):349-352. PubMed ID: 36647593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
